Medical Science Review Board

The MSRB comprises a range of leading experts and includes:

Professor Sharon Lewin AO is a world-leading infectious diseases expert, the inaugural Director of the Peter Doherty Institute for Infection and Immunity, a Professor of Medicine at The University of Melbourne and a National Health and Medical Research Council (NHMRC) Practitioner Fellow. Prof Lewin’s laboratory focuses on basic, translational and clinical research aimed at finding a cure for HIV and understanding the interaction between HIV and hepatitis B virus. She is also the Chief Investigator of a NHMRC Centre of Research Excellence (CRE), and works to bring together Australia’s leading experts in clinical, laboratory and public health research to address the key components required for a rapid and effective emergency response to infectious diseases.

Dr Elane Zelcer is Director of her own company, BioConsult Pty Ltd, and of organisations including the National Imaging Facility, AllergyPal Pty Ltd, the La Trobe University-Breakthrough Victoria Eagle Fund Investment Committee, and until recently, BioMelbourne Network. She has more than 30 years’ experience in healthtech, including director, executive management, consulting and academic roles. She works with and has advised SMEs, multinational companies, universities, CRCs and Australian and State Government committees, providing guidance on strategic decision-making, risk management, governance, capital raising and commercialisation.

Alan Liddle has over 30 years’ experience in developing and commercialising medical and biological therapeutics and in research & executive management in the medical and the biotechnology research sector. Alan is Executive Director of Sangui Bio a company he cofounded in 2014. Sangui is commercialising its discoveries in the role of red blood cells in immune system activation and regulation. Alan co-founded and was CEO & Director of Immune System Therapeutics Ltd from 2001 to 2011. He was also the Founder, CEO & Director of MicroMedical Industries Limited from 1986. Prior to his biomedical career Alan was a neuropsychologist researcher at the University of Sydney. He was the co-inventor of the rehabilitation software program: Dynamind3D. Alan holds a BA (Hons) from the University of Sydney and MBA from the University of NSW and is a fellow of the Australian Institute of Company Directors.

Professor Ross Coppel is Senior Deputy Dean and Director of Research of the Faculty of Medicine, Nursing and Health Sciences at Monash University. He is an internationally recognised scientist for his work in the fields of malaria and primary biliary cirrhosis. Ross was a member of the advisory committee that oversaw bioinformatics of the malaria genome project and he administered the malaria sequence database for the World Health Organization (WHO). He was a founder of the PlasmoDB consortium, a project to develop an organism-specific database that simplifies the analysis and exploitation of genomic sequence data by biologists. He is Director and a founding member of the Victorian Bioinformatics Consortium.

Dr Sarah Gutman is a cardiologist at The Alfred specialising in heart failure, transplantation and non-invasive imaging (including cardiac MRI, cardiac CT and echocardiography). She is Head of Cardiovascular MRI at the Baker Heart and Diabetes Institute. Her research interests include the use of cardiac MRI in risk stratification of heart failure patients and treating obesity in patients with heart failure.

.